XML 58 R49.htm IDEA: XBRL DOCUMENT
v3.21.2

Product and Geographic Sales Information (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2021
Segment Reporting [Abstract] |
Schedule of Revenue by reportable segment | The tables below show the Company’s disaggregated revenue for the periods presented:
| Three Months Ended September 30, |  |
| 2021 |  | 2020 |  |
Subscription revenues | $ | 246,467 |  |  | $ | 222,069 |  |  |
Transactional revenues | 85,354 |  |  | 64,398 |  |  |
Re-occurring revenues | 110,368 |  |  | — |  |  |
Total revenues, gross | 442,189 |  |  | 286,467 |  |  |
Deferred revenues adjustment (1) | (72) |  |  | (2,107) |  |  |
Total revenues, net | $ | 442,117 |  |  | $ | 284,360 |  |  |
(1) Reflects the deferred revenue adjustment as a result of purchase accounting. |  |  |  |  |
| Nine Months Ended September 30, |  |
| 2021 |  | 2020 |  |
Subscription revenues | $ | 725,121 |  |  | $ | 631,873 |  |  |
Transactional revenues | 259,300 |  |  | 174,000 |  |  |
Re-occurring revenues | 336,236 |  |  | — |  |  |
Total revenues, gross | 1,320,657 |  |  | 805,873 |  |  |
Deferred revenues adjustment (1) | (4,465) |  |  | (7,421) |  |  |
Total revenues, net | $ | 1,316,192 |  |  | $ | 798,452 |  |  |
(1) Reflects the deferred revenue adjustment as a result of purchase accounting.
The following table summarizes revenue by reportable segment for the periods indicated:
| Three Months Ended September 30, |  |
| 2021 |  | 2020 |  |
Science Segment | $ | 200,821 |  |  | $ | 188,701 |  |  |
Intellectual Property Segment | 241,296 |  |  | 95,659 |  |  |
Total Revenues | $ | 442,117 |  |  | $ | 284,360 |  |  |
| Nine Months Ended September 30, |  |
| 2021 |  | 2020 |  |
Science Segment | $ | 594,380 |  |  | $ | 514,774 |  |  |
Intellectual Property Segment | 721,812 |  |  | 283,678 |  |  |
Total Revenues | $ | 1,316,192 |  |  | $ | 798,452 |  |  |
Schedule of Segment Reporting Information, by Segment | Adjusted EBITDA by segment The following table presents segment profitability and a reconciliation to net income for the periods indicated:
| Three Months Ended September 30, |  |
| 2021 |  | 2020 (As Restated) |  |
Science Segment Adjusted EBITDA | $ | 113,771 |  |  | $ | 83,310 |  |  |
Intellectual Property Segment Adjusted EBITDA | 76,225 |  |  | 24,897 |  |  |
Total Adjusted EBITDA | $ | 189,996 |  |  | $ | 108,207 |  |  |
(Provision) benefit for income taxes | (3,579) |  |  | (4,325) |  |  |
Depreciation and amortization | (130,683) |  |  | (68,614) |  |  |
Interest, net | (65,194) |  |  | (20,244) |  |  |
Deferred revenues adjustment | (72) |  |  | (2,107) |  |  |
Transaction related costs | (11,851) |  |  | (34,938) |  |  |
Share-based compensation expense | (11,997) |  |  | (6,796) |  |  |
Restructuring and impairment | (15,621) |  |  | (3,192) |  |  |
Mark to market adjustment on financial instruments | 83,013 |  |  | (144,753) |  |  |
Other | (10,700) |  |  | (5,224) |  |  |
Net income (loss) | $ | 23,312 |  |  | $ | (181,986) |  |  |
Dividends on preferred shares | (22,431) |  |  | — |  |  |
Net income (loss) attributable to ordinary shares | $ | 881 |  |  | $ | (181,986) |  |  |
| Nine Months Ended September 30, |  |
| 2021 |  | 2020 (As Restated) |  |
Science Segment Adjusted EBITDA | $ | 305,119 |  |  | $ | 226,551 |  |  |
Intellectual Property Segment Adjusted EBITDA | 238,696 |  |  | 59,997 |  |  |
Total Adjusted EBITDA | $ | 543,815 |  |  | $ | 286,548 |  |  |
Provision for income taxes | (18,016) |  |  | (13,693) |  |  |
Depreciation and amortization | (392,513) |  |  | (176,200) |  |  |
Interest, net | (141,156) |  |  | (72,306) |  |  |
Deferred revenues adjustment | (4,465) |  |  | (7,421) |  |  |
Transaction related costs | 1,599 |  |  | (70,154) |  |  |
Share-based compensation expense | (38,518) |  |  | (31,121) |  |  |
Restructuring and impairment | (121,988) |  |  | (26,792) |  |  |
Mark to market adjustment on financial instruments | 113,207 |  |  | (224,175) |  |  |
Other | (24,817) |  |  | (1,586) |  |  |
Net loss | $ | (82,852) |  |  | $ | (336,900) |  |  |
Dividends on preferred shares | (22,431) |  |  | — |  |  |
Net loss attributable to ordinary shares | $ | (105,283) |  |  | $ | (336,900) |  |  |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration